Intracellular Therapies
1 known investors
Intra-Cellular Therapies develops treatments for neuropsychiatric, neurologic, and related disorders, including its product CAPLYTA. The company is now part of Johnson & Johnson.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Intracellular Therapies do?
- Intra-Cellular Therapies develops treatments for neuropsychiatric, neurologic, and related disorders, including its product CAPLYTA. The company is now part of Johnson & Johnson.
- Who are Intracellular Therapies's investors?
- Intracellular Therapies's investors include Scientia Ventures.